Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling.

Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM, Lee Y, Kim HH.

Cell Death Differ. 2009 Oct;16(10):1332-43. doi: 10.1038/cdd.2009.74. Epub 2009 Jun 19.

2.

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F.

PLoS One. 2009;4(4):e4992. doi: 10.1371/journal.pone.0004992. Epub 2009 Apr 7. Erratum in: PLoS One. 2013; 8(3). doi:10.1371/annotation/4ab4c130-16cb-41f0-9507-b00ce070fbc6.

3.

The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells.

Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K, Danka ES, Henkle SL, Scandurro AB.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3806-11. doi: 10.1073/pnas.0900244106. Epub 2009 Feb 20.

4.

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L, Karin M.

Cancer Cell. 2009 Feb 3;15(2):103-13. doi: 10.1016/j.ccr.2009.01.001. Erratum in: Cancer Cell. 2009 Mar 3;15(3):241.

5.

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, Bennecke M, Bateman T, Nebelsiek T, Lundgren-May T, Canli O, Schwitalla S, Matthews V, Schmid RM, Kirchner T, Arkan MC, Ernst M, Greten FR.

Cancer Cell. 2009 Feb 3;15(2):91-102. doi: 10.1016/j.ccr.2009.01.002.

6.

Human mesenchymal stem cells may be involved in keloid pathogenesis.

Akino K, Akita S, Yakabe A, Mineda T, Hayashi T, Hirano A.

Int J Dermatol. 2008 Nov;47(11):1112-7. doi: 10.1111/j.1365-4632.2008.03380.x.

PMID:
18986439
7.

Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction.

Ogura H, Murakami M, Okuyama Y, Tsuruoka M, Kitabayashi C, Kanamoto M, Nishihara M, Iwakura Y, Hirano T.

Immunity. 2008 Oct 17;29(4):628-36. doi: 10.1016/j.immuni.2008.07.018. Epub 2008 Oct 9.

8.

Isolation and characterization of multipotent human keloid-derived mesenchymal-like stem cells.

Moon JH, Kwak SS, Park G, Jung HY, Yoon BS, Park J, Ryu KS, Choi SC, Maeng I, Kim B, Jun EK, Kim S, Kim A, Oh S, Kim H, Kim KD, You S.

Stem Cells Dev. 2008 Aug;17(4):713-24. doi: 10.1089/scd.2007.0210.

PMID:
18710345
9.

Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells.

Momcilović M, Miljković Z, Popadić D, Marković M, Savić E, Ramić Z, Miljković D, Mostarica-Stojković M.

BMC Immunol. 2008 Aug 12;9:47. doi: 10.1186/1471-2172-9-47.

10.

Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents.

Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, Le A, Wang CY, Chen W, Shi S.

PLoS One. 2008 Jul 9;3(7):e2615. doi: 10.1371/journal.pone.0002615.

11.

Induction and effector functions of T(H)17 cells.

Bettelli E, Korn T, Oukka M, Kuchroo VK.

Nature. 2008 Jun 19;453(7198):1051-7. doi: 10.1038/nature07036. Review.

PMID:
18563156
12.

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D.

Cancer Res. 2008 Jun 1;68(11):4331-9. doi: 10.1158/0008-5472.CAN-08-0943.

13.

IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.

Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA.

Nature. 2008 Jul 17;454(7202):350-2. doi: 10.1038/nature07021. Epub 2008 May 11.

14.

The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat.

Manel N, Unutmaz D, Littman DR.

Nat Immunol. 2008 Jun;9(6):641-9. doi: 10.1038/ni.1610. Epub 2008 May 4.

15.

A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses.

Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V.

Nat Immunol. 2008 Jun;9(6):650-7. doi: 10.1038/ni.1613. Epub 2008 May 4.

PMID:
18454150
16.

Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.

Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F.

Gene Ther. 2008 May;15(10):730-8. doi: 10.1038/gt.2008.39. Epub 2008 Apr 10. Review.

PMID:
18401438
17.

Decline in self-renewal factors contributes to aging of the stem cell niche in the Drosophila testis.

Boyle M, Wong C, Rocha M, Jones DL.

Cell Stem Cell. 2007 Oct 11;1(4):470-8. doi: 10.1016/j.stem.2007.08.002.

18.

Stem cell aging is controlled both intrinsically and extrinsically in the Drosophila ovary.

Pan L, Chen S, Weng C, Call G, Zhu D, Tang H, Zhang N, Xie T.

Cell Stem Cell. 2007 Oct 11;1(4):458-69. doi: 10.1016/j.stem.2007.09.010.

19.

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland.

Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB, Chieco P, Bonafè M.

J Clin Invest. 2007 Dec;117(12):3988-4002.

20.

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ.

Nat Immunol. 2007 Dec;8(12):1390-7. Epub 2007 Nov 11.

PMID:
17994024

Supplemental Content

Support Center